Log in

Role of Lymph Node Dissection in Small (≤ 3 cm) Intrahepatic Cholangiocarcinoma

  • 2018 SSAT Plenary Presentation
  • Published:
Journal of Gastrointestinal Surgery

Abstract

Background and Aims

The role of lymph node dissection (LND) in patients with small intrahepatic cholangiocarcinoma (ICC) is still under debate.

The aims of this study were to compare the lymph node (LN) status and its correlation with survival among patients with ICC stratified by tumor size.

Methods

A retrospective analysis of a multi-institutional series of 259 patients undergoing curative-intent surgery was carried out. Patients were stratified into Small-ICC (≤ 3 cm) and Large-ICC (> 3 cm) based on tumor size.

Results

There were 53 and 206 patients in Small-ICC and Large-ICC groups, respectively. The incidence of LND was 62% among Small-ICC patients and 78% among Large-ICC patients (p = 0.016). LN metastases were identified in 30.3% and 38.5% of Small-ICC and Large-ICC patients, respectively (p = 0.37). No differences in terms of number of harvested LN and LN metastases were identified comparing Small- and Large-ICC patients. The 5-year overall survival (OS) was 52.6% for Small-ICC and 36.2% for Large-ICC (p = 0.024). The 5-year OS according to the LN status (N0 vs N+) was 84.8% and 36.0% (p = 0.032) in Small-ICC, and 45.7% and 12.1% in Large-ICC (p < 0.001), respectively.

Conclusion

While Small-ICC patients with no LN metastasis had a good long-term survival, the LN resulted in an important variable associated with survival also for patients in this group. Moreover, the incidence of LN metastasis did not differ when comparing Small-ICC and Large-ICC patients, suggesting that LND is mandatory in the surgical treatment of ICC regardless of tumor size.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gupta A, Dixon E. Epidemiology and risk factors: intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr 2017;6(2):101–104.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: A true increase? J Hepatol 2004;40(3):472–477.

    Article  PubMed  Google Scholar 

  3. William C. Palmer, MD and Tushar Patel. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 2012;57(1):69–76.

    Article  Google Scholar 

  4. Ruzzenente A, Conci S, Valdegamberi A, Pedrazzani C, Guglielmi A. Role of surgery in the treatment of intrahepatic cholangiocarcinoma. Eur Rev Med Pharmacol Sci 2015;19(15):2892–900.

    CAS  PubMed  Google Scholar 

  5. de Jong M.C., Nathan H., Sotiropoulos G.C., Paul A., Alexandrescu S., Marques H. et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011;29:3140–3145.

    Article  PubMed  Google Scholar 

  6. Bagante F., Spolverato G.; Weiss M., Alexandrescu s., Marques H., Aldrighetti L. et al. Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma. J Gastrointest Surg 2017; 21:1888–1897.

    Article  PubMed  Google Scholar 

  7. Spolverato G, Kim Y, Ejaz A, Alexandrescu S, Marques H, Aldrighetti L, et al. Conditional probability of long-term survival after liver resection for intrahepatic cholangiocarcinoma: a multiinstitutional analysis of 535 patients. JAMA Surg 2015;150:538–545.

    Article  PubMed  Google Scholar 

  8. Ribero D, Pinna AD, Guglielmi A, Ponti A, Nuzzo G, et al. Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients. Arch Surg 2012;147(12):1107–13.

    Article  PubMed  Google Scholar 

  9. Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 2014;149:565–574.

    Article  PubMed  Google Scholar 

  10. Sakamoto Y, Kokudo N, Matsuyama Y, et al. Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan. Cancer 2016;122:61–70.

    Article  PubMed  Google Scholar 

  11. Sapisochin G, Facciuto M, Rubbia-Brandt L, et al. Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment. Hepatology 2016;64:1178–88.

    Article  CAS  PubMed  Google Scholar 

  12. Adachi T, Eguchi S. Lymph node dissection for intrahepatic cholangiocarcinoma: a critical review of the literature to date. J Hepatobiliary Pancreat Sci 2014;21:162–8.

    Article  PubMed  Google Scholar 

  13. Jutric Z, Johnston WC, Hoen HM, et al. Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database. HPB 2016;18(1):79–87.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Bagante F, Gani F, Spolverato G, et al.: Intrahepatic cholangiocarcinoma: Prognosis of patients who did not undergo lymphadenectomy. J Am Coll Surg 2015;221:1031–1040.

    Article  PubMed  Google Scholar 

  15. Guglielmi A, Ruzzenente A, Campagnaro T, et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. J Gastrointest Surg 2013;17(11):1917–28.

    Article  PubMed  Google Scholar 

  16. Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Sueda T. Intrahepatic cholangiocarcinoma: clinicopathological differences between peripheral type and hilar type. J Gastrointest Surg 2012;16:540–8

    Article  PubMed  Google Scholar 

  17. Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Ann Surg Oncol 2010;17:1816–22

    Article  PubMed  Google Scholar 

  18. Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer TW et al. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg 2014;149:432–438.

    Article  PubMed  Google Scholar 

  19. Zhang XF, Chakedis J, Bagante F, Chen Q, Beal EV, Lv Y, et al. Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma. Br J Surg 2018;105(7):857–866.

    Article  PubMed  Google Scholar 

  20. Amini N., Ejaz A., Spolverato G., Maithel S.K., Kim Y., Pawlik T.M. Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review. J Gastrointest Surg 2014;18:2136–2148.

    Article  PubMed  Google Scholar 

  21. Nakagawa T, Kamiyama T, Kurauchi N, Matsushita M, Nakanishi K, Kamachi H et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 2005;29(6):728–33.

    Article  PubMed  Google Scholar 

  22. Dhanasekaran R, Hemming AW, Zendejas I, George T, Nelson DR, Soldevila-Pico C, et al. Treatment outcomes and prognostic factors of intra-hepatic cholangiocarcinoma. Oncol Rep 2013;29:1259–1267.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 2009;33(6):1247–54.

    Article  PubMed  Google Scholar 

  24. Wang Y, Li J, **a Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 2013;31(9):1188–1195

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Calogero Iacono.

Ethics declarations

Data collection and analysis were performed according to the institutional guidelines and were conformed to the ethical standards of the World Medical Association (Declaration of Helsinki). The study was approved by each local ethical committee, and signed consent was obtained from all the subjects included in the study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Figure S1

Overall survival between Large-ICC and Small-ICC according to the different LN Status: A, N0 (p = 0.028); B, N+ (p = 0.048); C, NX (p = 0.985). (PPTX 3715 kb)

Figure S2

Overall survival between Large-ICC and Small-ICC according to the different LN Status (N0, N+ and NX) (p = 0.001). (PPTX 1272 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruzzenente, A., Conci, S., Viganò, L. et al. Role of Lymph Node Dissection in Small (≤ 3 cm) Intrahepatic Cholangiocarcinoma. J Gastrointest Surg 23, 1122–1129 (2019). https://doi.org/10.1007/s11605-019-04108-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-019-04108-0

Keywords

Navigation